RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection Jun 15, 2017
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug Jun 14, 2017 Life Science
RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S Jun 14, 2017 Life Science
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis Jun 14, 2017 Life Science
Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017 Jun 5, 2017 Life Science
Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, Spain Jun 1, 2017 Life Science
Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone May 30, 2017 Life Science
Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and Success May 23, 2017 Life Science
DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2017 Financial Results May 19, 2017 Life Science
Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial May 15, 2017 Life Science
DelMar Formalizes Collaboration with PRA Health Sciences for Phase 3 Trial of VAL-083 in Recurrent Glioblastoma Multiforme (GBM) May 12, 2017 Life Science
